Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues.

Roulis E, Bachmann NL, Myers GS, Huston W, Summersgill J, Hudson A, Dreses-Werringloer U, Polkinghorne A, Timms P.

Genomics. 2015 Dec;106(6):373-83. doi: 10.1016/j.ygeno.2015.09.008. Epub 2015 Sep 28.

2.

Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.

Vingtdeux V, Tanis JE, Chandakkar P, Zhao H, Dreses-Werringloer U, Campagne F, Foskett JK, Marambaud P.

PLoS One. 2014 Nov 11;9(11):e112484. doi: 10.1371/journal.pone.0112484. eCollection 2014.

3.

CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.

Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, Marambaud P.

J Cell Sci. 2013 Mar 1;126(Pt 5):1199-206. doi: 10.1242/jcs.117135. Epub 2013 Jan 23.

4.

Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages.

Capiralla H, Vingtdeux V, Venkatesh J, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P.

FEBS J. 2012 Oct;279(20):3791-9. doi: 10.1111/j.1742-4658.2012.08739.x. Epub 2012 Sep 4.

5.

CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.

Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, Marambaud P.

Mol Med. 2011 Sep-Oct;17(9-10):974-9. doi: 10.2119/molmed.2011.00154. Epub 2011 May 24.

6.

Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.

Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman MM, Kleinman JE, Davies P, Goldberg TE.

Mol Psychiatry. 2011 Aug;16(8):836-47. doi: 10.1038/mp.2010.57. Epub 2010 May 18.

7.

Performance-based measures of everyday function in mild cognitive impairment.

Goldberg TE, Koppel J, Keehlisen L, Christen E, Dreses-Werringloer U, Conejero-Goldberg C, Gordon ML, Davies P.

Am J Psychiatry. 2010 Jul;167(7):845-53. doi: 10.1176/appi.ajp.2010.09050692. Epub 2010 Apr 1.

8.

Calcium signaling in neurodegeneration.

Marambaud P, Dreses-Werringloer U, Vingtdeux V.

Mol Neurodegener. 2009 May 6;4:20. doi: 10.1186/1750-1326-4-20.

9.

Therapeutic potential of resveratrol in Alzheimer's disease.

Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S6. doi: 10.1186/1471-2202-9-S2-S6. Review.

10.

Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.

Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gérard HC, Whittum-Hudson JA, Hudson AP.

Int J Med Microbiol. 2009 Mar;299(3):187-201. doi: 10.1016/j.ijmm.2008.07.002. Epub 2008 Sep 30.

11.

Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants.

Zhao H, Dreses-Werringloer U, Davies P, Marambaud P.

BMC Res Notes. 2008 Jun 30;1:38. doi: 10.1186/1756-0500-1-38.

12.

A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett JK, Campagne F, Marambaud P.

Cell. 2008 Jun 27;133(7):1149-61. doi: 10.1016/j.cell.2008.05.048.

13.

Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain.

Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, Hudson AP.

FEMS Immunol Med Microbiol. 2006 Dec;48(3):355-66. Epub 2006 Oct 18.

14.

Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype.

Dreses-Werringloer U, Gérard HC, Whittum-Hudson JA, Hudson AP.

Am J Med Sci. 2006 Oct;332(4):168-74.

PMID:
17031241
15.

Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.

Dreses-Werringloer U, Padubrin I, Köhler L, Hudson AP.

Antimicrob Agents Chemother. 2003 Jul;47(7):2316-8.

16.

Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Dreses-Werringloer U, Padubrin I, Zeidler H, Köhler L.

Antimicrob Agents Chemother. 2001 Nov;45(11):3001-8.

17.

Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Dreses-Werringloer U, Padubrin I, Jürgens-Saathoff B, Hudson AP, Zeidler H, Köhler L.

Antimicrob Agents Chemother. 2000 Dec;44(12):3288-97.

18.

Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction.

Kuipers JG, Nietfeld L, Dreses-Werringloer U, Koehler L, Wollenhaupt J, Zeidler H, Hammer M.

Ann Rheum Dis. 1999 Feb;58(2):103-8.

19.

Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-gamma.

Nettelnbreker E, Zeidler H, Bartels H, Dreses-Werringloer U, Däubener W, Holtmann H, Köhler L.

J Med Microbiol. 1998 Feb;47(2):141-9.

PMID:
9879957

Supplemental Content

Loading ...
Support Center